Background Atherosclerosis represents a cardiovascular risk. Chronic inflammation is a key factor for atherogenic progression. Neutrophil‐to‐lymphocyte ratio (NLR) has been proposed as a novel biomarker for cardiovascular risks. We aimed to explore whether NLR was related to surrogate pro‐atherogenic promoters driving atherogenic progression, as measured by carotid intima‐media thickness (CIMT). Study Design Thirty‐one patients with obesity candidates for bariatric surgery were recruited from Centro Médico Nacional “20 de Noviembre”, ISSSTE, Mexico City. The results are part of the “CROP” study (NCT03561987). NLR was calculated from routine complete blood count, and its relation with plasma pro‐inflammatory mediators (hsCRP, TNF‐α and IL‐1β), adipokines (adiponectin and leptin), adiposity markers (visceral adipose tissue VAT determined from CT scan image and VAT individual adipocyte area at histological sample) and CIMT were determined. Results Neutrophil‐to‐lymphocyte ratio correlated with hsCRP (Spearman's r = 0.70 95% CI 0.46 to 0.85, P < 0.01), TNF‐α (r = 0.69 0.44 to 0.84, P < 0.0001) and adiponectin (r = −0.69 −0.84 to −0.45, P < 0.03), as well as with VAT individual adipocyte area (r = 0.64 0.37 to 0.81, P < 0.0001) and with VAT area (r = 0.43; 0.07 to 0.68, P < 0.01). Leptin and adiponectin showed further independent association with higher NLR (multivariate regression analysis OR 7.9 95% CI 1.1 to 56.2 P = 0.03 and 0.1 0.01 to 1.0 P = 0.05, respectively). Moreover, NLR distribution significantly varied between subgroups divided according to progressive CIMT (P = 0.05); whereas adiponectin and VAT adipocyte area associated with CIMT > 0.9 mm (univariate analysis OR 0.1 0.01 to 1.0 P = 0.05 and 13.1 1.4 to 126.3 P = 0.03, respectively). Conclusion Neutrophil‐to‐lymphocyte ratio was related to pro‐inflammatory, adiposity biomarkers and progressive subclinical atherogenesis.